ArticleBlood advances2022

Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma.

Jessica S Little et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.